What does Eyed Pharma do?
EYED PHARMA specializes in developing innovative pharmaceutical solutions for eye care. The company focuses on creating treatments and products that enhance the quality of life for patients with ocular conditions. With a commitment to research and development, EYED PHARMA aims to address unmet medical needs in ophthalmology.
- Signals
-
Reporting lossesReporting losses € -6.92M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.45MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -2.70MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 17.37MStrong equity provides a buffer against setbacks.
Low riskLow risk 34.3%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.98A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
High turnoverHigh turnover € 10.49MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 11.0%Social debts stay manageable relative to personnel costs.
- Shareholders
- Fund+ 6,66%, Qbic Ii Fund Arkiv 4,06%, Ophtalmologie Chirurgicale Van Cauwenberge Rakic 2,67%, +1 more
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Turnover
|
€
10.49M
|
|
|
|
|
€
531K
|
€
254K
|
€
1.10M
|
€
1.09M
|
|
|
€
-2.70M
|
€
-3.90M
|
€
-3.57M
|
€
-4.56M
|
|
|
€
-6.92M
|
€
-6.94M
|
€
-6.03M
|
€
-6.31M
|
|
|
€
17.37M
|
€
22.78M
|
€
27.52M
|
€
16.30M
|
|
|
34.32%
|
53.82%
|
72.69%
|
60.11%
|
|
|
€
33.24M
|
€
19.55M
|
€
10.34M
|
€
10.81M
|
|
|
€
1.30M
|
€
1.21M
|
€
1.03M
|
€
3.47M
|
|
|
26
|
32
|
34.20
|
40.50
|
Publications 21
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions - Demissions, Nominations 23/11/2023
- Demissions, Nominations 04/04/2023
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions - Demissions, Nominations 24/01/2023
- Siege Social 23/05/2022
- Statuts (Traduction, Coordination, Autres Modifications, ) - Capital, Actions - Demissions, Nominations 27/12/2021
Frequently asked questions
Answers to the most common questions about Eyed Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Eyed Pharma?
The VAT number of Eyed Pharma is BE0508.599.605.
How many employees work at Eyed Pharma?
In 2025, Eyed Pharma employed 26.00 full-time equivalents (FTE).
When was Eyed Pharma established?
Eyed Pharma was founded in 20-12-2012.
What is the official address of Eyed Pharma?
The official address of Eyed Pharma is Rue Louis Plescia 9 Seraing 4102.
What is the legal form of Eyed Pharma?
The juridical form of Eyed Pharma is Public limited company (NV/SA).
What is the annual revenue of Eyed Pharma?
The revenue of Eyed Pharma for the 2025 financial year was €10,494,903.
What does Eyed Pharma do?
EYED PHARMA specializes in developing innovative pharmaceutical solutions for eye care. The company focuses on creating treatments and products that enhance the quality of life for patients with ocular conditions. With a commitment to research and development, EYED PHARMA aims to address unmet medical needs in ophthalmology.
Is Eyed Pharma a reliable company?
Eyed Pharma is a registered Rechtspersoon with company number 0508.599.605 and can be verified through the official CBE database.
What is the credit limit of Eyed Pharma?
The estimated credit limit of Eyed Pharma is €989,932.
Is Eyed Pharma still active?
Eyed Pharma currently has the status "Normal situation" and is active.